AV
Atlas Venture Opportunity Fund II, L.P.
Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Atlas Venture Opportunity Fund II, L.P.. Insider active across 2 companies, notably Korro Bio, Inc.. Aggregated, 17 reports have been logged. History available since 22 June 2026. The latest transaction was filed on 26 August 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Atlas Venture Opportunity Fund II, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations17 total
51 shares@ US$13.73Common StockSEC144:0001628280-26-059121
4,884 shares@ US$13.220.032% mcap3.4% of flowCommon StockSEC144:0001628280-26-058029
478,377 shares@ US$25.960.26% mcap51.9% of flowCommonSEC144:0001628280-26-057188
94,415 shares@ US$26.170.050% mcap21.5% of flowCommonSEC144:0001628280-26-056844
368 shares@ US$13.490.0025% mcap0.3% of flowCommon StockSEC144:0001628280-26-055859
77,387 shares@ US$22.840.045% mcap37.6% of flowCommonSEC144:0001628280-26-047532
8,506 shares@ US$14.000.058% mcap8.5% of flowCommon StockSEC144:0001628280-26-047351
127,182 shares@ US$23.070.075% mcap62.4% of flowCommonSEC144:0001628280-26-047355
14,745 shares@ US$13.650.095% mcap15.8% of flowCommon StockSEC144:0001628280-26-046980
51,756 shares@ US$20.940.022% mcap14.5% of flowCommonSEC144:0001628280-26-046096
81,903 shares@ US$20.610.035% mcap22.7% of flowCommonSEC144:0001628280-26-045820
6,382 shares@ US$20.330.0027% mcap1.5% of flowCommonSEC144:0001628280-26-045613
7,093 shares@ US$13.710.048% mcap5.5% of flowCommon StockSEC144:0001628280-26-045301
25,397 shares@ US$20.260.011% mcap5.8% of flowCommonSEC144:0001628280-26-045297
17,426 shares@ US$13.900.12% mcap13.7% of flowCommon StockSEC144:0001628280-26-044983
39,131 shares@ US$20.870.017% mcap9.2% of flowCommonSEC144:0001628280-26-044987
3,661 shares@ US$12.990.023% mcap2.7% of flowCommon StockSEC144:0001628280-26-044737
About Atlas Venture Opportunity Fund II, L.P.
Atlas Venture Opportunity Fund II, L.P. is a shareholder of Dyne Therapeutics, Inc. and Korro Bio, Inc. The declarant has 12 filings in total, and across the 12 recent filings covered, they correspond to sales of EUR 8,449,574, with a modal transaction nature of notice of proposed sale (Form 144), between 2026-06-22 and 2026-07-07.